Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.23.2
Stockholders' Equity (Details) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Jun. 16, 2023
Jan. 26, 2023
May 31, 2020
Jun. 30, 2023
Dec. 31, 2022
Jun. 22, 2023
Jun. 15, 2023
Jun. 01, 2023
May 24, 2023
Stockholders’ Equity (Details) [Line Items]                  
Restricted stock units 216,667 11,332              
Common stock shares issued           48,948     102,096
Accounts payable (in Dollars)           $ 17,621     $ 26,545
Price per share (in Dollars per share)     $ 3.8     $ 0.36     $ 0.26
Common stock, share issued       16,159,878 13,010,409 300,000   300,000  
Aggregate net proceeds (in Dollars)           $ 134,634   $ 127,053  
Shares of common stock             228,568    
Warrants to purchase shares     169,409       823,078    
Common stock per share (in Dollars per share)       $ 0.001 $ 0.001   $ 0.65    
Received amount (in Dollars)     $ 515,000            
Sale amount (in Dollars)     $ 565,000            
Shares of common stock     135,527            
Exercise price (in Dollars per share)     $ 4            
Shares and warrants (in Dollars)       $ 415,000          
Equity financing (in Dollars)       125,000 $ 125,000        
Unrecognized expense (in Dollars)       $ 148,240 $ 222,000        
Series A Convertible Preferred Stock [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Common shares       45,000,000          
Convertible preferred shares authorized       900,000          
Convertible preferred shares par value of per share (in Dollars per share)       $ 0.001